Howe & Rusling’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-4,111
Closed -$227K 494
2025
Q3
$227K Sell
4,111
-804
-16% -$41.8K 0.02% 275
2025
Q2
$212K Sell
4,915
-502
-9% -$19.4K 0.02% 277
2025
Q1
$214K Sell
5,417
-378
-7% -$16.7K 0.02% 258
2024
Q4
$236K Hold
5,795
0.02% 235
2024
Q3
$226K Hold
5,795
0.02% 237
2024
Q2
$253K Hold
5,795
0.02% 216
2024
Q1
$276K Buy
+5,795
New +$260K 0.03% 214
2023
Q4
Sell
-5,852
Closed -$279K 386
2023
Q3
$279K Buy
5,852
+191
+3% +$10.4K 0.03% 182
2023
Q2
$329K Buy
5,661
+947
+20% +$56.8K 0.04% 169
2023
Q1
$337K Buy
4,714
+351
+8% +$27.9K 0.04% 169
2022
Q4
$307K Buy
4,363
+129
+3% +$9.09K 0.04% 164
2022
Q3
$257K Buy
4,234
+373
+10% +$25K 0.03% 178
2022
Q2
$244K Buy
3,861
+248
+7% +$16.2K 0.03% 180
2022
Q1
$231K Buy
3,613
+385
+12% +$25.8K 0.03% 190
2021
Q4
$231K Buy
3,228
+211
+7% +$16K 0.03% 189
2021
Q3
$215K Sell
3,017
-68
-2% -$5.36K 0.03% 188
2021
Q2
$251K Sell
3,085
-434
-12% -$34.9K 0.03% 164
2021
Q1
$266K Buy
3,519
+547
+18% +$39.8K 0.04% 153
2020
Q4
$225K Buy
2,972
+689
+30% +$44.9K 0.03% 156
2020
Q3
$113K Buy
2,283
+1,874
+458% +$106K 0.02% 198
2020
Q2
$22K Buy
+409
New +$19.4K ﹤0.01% 339
2020
Q1
Sell
-130
Closed -$11K 841
2019
Q4
$11K Hold
130
﹤0.01% 459
2019
Q3
$11K Hold
130
﹤0.01% 457
2019
Q2
$14K Hold
130
﹤0.01% 409
2019
Q1
$14K Hold
130
﹤0.01% 409
2018
Q4
$11K Hold
130
﹤0.01% 429
2018
Q3
$13K Buy
+130
New +$12.6K ﹤0.01% 455

Other funds holding NGVT

Howe & Rusling's NGVT Position: Q4 2025 in Review

Howe & Rusling sold out of Ingevity (NGVT) in Q4 2025, closing a stake of 4,111 shares — an estimated $227K sold.

Howe & Rusling first reported a position in NGVT in Q3 2018 and held it in 27 quarters. The position peaked at $337K in Q1 2023. 303 funds tracked by Wall St. Rank hold NGVT as of Q4 2025.

  • Howe & Rusling reported no remaining Ingevity position as of Q4 2025 after selling out during the quarter.
  • Howe & Rusling sold 4,111 Ingevity shares in Q4 2025, an estimated $227K.
  • Howe & Rusling first reported a position in Ingevity in Q3 2018 and held it in 27 quarters.
  • Howe & Rusling's Ingevity position peaked at $337K in Q1 2023.
  • 303 funds tracked by Wall St. Rank held Ingevity as of Q4 2025.

Based on Howe & Rusling's 13F filing for Q4 2025, filed 17 Feb 2026.